伴随性过敏和鼻炎以及喘和COPD的患者相关结果:一个横截面研究
Zainab Al-Hadrawi1, Maaike Giezeman2,3, Mikael Hasselgren2,3
1Department of Respiratory Medicine, Örebro University Hospital, Örebro, Sweden.
European clinical respiratory journal
|September 4, 2024
概括
喘中的过敏状况比COPD更为普遍,但当过敏和鼻炎存在时,这两种疾病的结果都更差. 这些并发症的早期诊断和治疗对于改善患者健康至关重要.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 过敏学 过敏学
- 临床流行病学 临床流行病学
背景情况:
- 伴随性过敏表现和鼻炎在呼吸系统疾病中很常见.
- 了解它们对喘和COPD患者结果的影响对于有效管理至关重要.
研究的目的:
- 为了比较喘患者和COPD患者过敏表现和鼻炎的患病率.
- 调查这些并发症与患者相关结果之间的关联,包括症状控制,恶化和疾病严重程度.
主要方法:
- 一项横截面研究,涉及随机选择的瑞典患者,他们被诊断患有喘 (n=1291) 或COPD (n=1329).
- 通过自行填写问卷和医疗记录审查收集的数据,评估人口统计,过敏症状,鼻炎,恶化和验证的结果得分 (ACT,CAT).
- 还记录了过敏测试的流行情况.
主要成果:
- 过敏症状在喘 (75%) 比COPD (38%) 更常见,鼻炎报告在70%的喘患者和58%的COPD患者中.
- 在喘患者中,过敏和鼻炎独立地与症状控制不良,恶化增加和自我评估中度/严重疾病有关.
- 在COPD患者中,过敏和鼻炎独立地与较低的健康状况,更多的恶化和自我评估的中度/严重疾病有关.
结论:
- 与COPD相比,喘中的过敏表现和鼻炎的发生率明显高.
- 这些并发症独立地与喘和COPD的患者相关结果较差有关.
- 这些发现强调了查并管理喘和COPD患者的并发性过敏和鼻炎的重要性.
相关概念视频
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362


